[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Dermatology Drug Market Professional Survey Report 2018

June 2018 | 111 pages | ID: G0E54DC8A7BEN
QYResearch

US$ 3,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report studies the global Dermatology Drug market status and forecast, categorizes the global Dermatology Drug market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).
Dermatology Drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases.
The classification of Dermatology Drug includes External Use, Oral and Injection, and the revenue proportion of External Use in 2015 is about 73.74%.
Dermatology Drug is widely used for Psoriasis, Skin Infections, Acne, Dermatitis and other skin diseases. Amongst these different types of skin diseases, Psoriasis was the largest revenue generating segment in 2015, and the revenue market share is about 48.04%.

The global Dermatology Drug market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

The major manufacturers covered in this report
  • AbbVie
  • Johnson & Johnson
  • Bayer
  • Galderma
  • Bristol-Myers Squibb
  • Novartis
  • Pfizer
  • Merz Pharma
  • Valeant
  • LEO Pharma
  • GlaxoSmithKline
Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
  • North America
  • Europe
  • China
  • Japan
  • India
  • Southeast Asia
  • Other regions (Central & South America, Middle East & Africa)
We can also provide the customized separate regional or country-level reports, for the following regions:
  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Indonesia
    • Singapore
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Central & South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • Turkey
    • Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • External Use
  • Oral
  • Injection
By Application, the market can be split into
  • Psoriasis
  • Skin Infections
  • Acne
  • Dermatitis
  • Other
The study objectives of this report are:
  • To analyze and study the global Dermatology Drug capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
  • Focuses on the key Dermatology Drug manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Dermatology Drug are as follows:
  • History Year: 2013-2017
  • Base Year: 2017
  • Estimated Year: 2018
  • Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Dermatology Drug Manufacturers
Dermatology Drug Distributors/Traders/Wholesalers
Dermatology Drug Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
  • With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
  • Regional and country-level analysis of the Dermatology Drug market, by end-use.
  • Detailed analysis and profiles of additional market players.
Global Dermatology Drug Market Professional Survey Report 2018

1 INDUSTRY OVERVIEW OF DERMATOLOGY DRUG

1.1 Definition and Specifications of Dermatology Drug
  1.1.1 Definition of Dermatology Drug
  1.1.2 Specifications of Dermatology Drug
1.2 Classification of Dermatology Drug
  1.2.1 External Use
  1.2.2 Oral
  1.2.3 Injection
1.3 Applications of Dermatology Drug
  1.3.1 Psoriasis
  1.3.2 Skin Infections
  1.3.3 Acne
  1.3.4 Dermatitis
  1.3.5 Other
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 Europe
  1.4.3 China
  1.4.4 Japan
  1.4.5 Southeast Asia
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF DERMATOLOGY DRUG

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Dermatology Drug
2.3 Manufacturing Process Analysis of Dermatology Drug
2.4 Industry Chain Structure of Dermatology Drug

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF DERMATOLOGY DRUG

3.1 Capacity and Commercial Production Date of Global Dermatology Drug Major Manufacturers in 2017
3.2 Manufacturing Plants Distribution of Global Dermatology Drug Major Manufacturers in 2017
3.3 R&D Status and Technology Source of Global Dermatology Drug Major Manufacturers in 2017
3.4 Raw Materials Sources Analysis of Global Dermatology Drug Major Manufacturers in 2017

4 GLOBAL DERMATOLOGY DRUG OVERALL MARKET OVERVIEW

4.1 2013-2018E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2013-2018E Global Dermatology Drug Capacity and Growth Rate Analysis
  4.2.2 2017 Dermatology Drug Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2013-2018E Global Dermatology Drug Sales and Growth Rate Analysis
  4.3.2 2017 Dermatology Drug Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2013-2018E Global Dermatology Drug Sales Price
  4.4.2 2017 Dermatology Drug Sales Price Analysis (Company Segment)

5 DERMATOLOGY DRUG REGIONAL MARKET ANALYSIS

5.1 North America Dermatology Drug Market Analysis
  5.1.1 North America Dermatology Drug Market Overview
  5.1.2 North America 2013-2018E Dermatology Drug Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2013-2018E Dermatology Drug Sales Price Analysis
  5.1.4 North America 2017 Dermatology Drug Market Share Analysis
5.2 Europe Dermatology Drug Market Analysis
  5.2.1 Europe Dermatology Drug Market Overview
  5.2.2 Europe 2013-2018E Dermatology Drug Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 Europe 2013-2018E Dermatology Drug Sales Price Analysis
  5.2.4 Europe 2017 Dermatology Drug Market Share Analysis
5.3 China Dermatology Drug Market Analysis
  5.3.1 China Dermatology Drug Market Overview
  5.3.2 China 2013-2018E Dermatology Drug Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 China 2013-2018E Dermatology Drug Sales Price Analysis
  5.3.4 China 2017 Dermatology Drug Market Share Analysis
5.4 Japan Dermatology Drug Market Analysis
  5.4.1 Japan Dermatology Drug Market Overview
  5.4.2 Japan 2013-2018E Dermatology Drug Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Japan 2013-2018E Dermatology Drug Sales Price Analysis
  5.4.4 Japan 2017 Dermatology Drug Market Share Analysis
5.5 Southeast Asia Dermatology Drug Market Analysis
  5.5.1 Southeast Asia Dermatology Drug Market Overview
  5.5.2 Southeast Asia 2013-2018E Dermatology Drug Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Southeast Asia 2013-2018E Dermatology Drug Sales Price Analysis
  5.5.4 Southeast Asia 2017 Dermatology Drug Market Share Analysis
5.6 India Dermatology Drug Market Analysis
  5.6.1 India Dermatology Drug Market Overview
  5.6.2 India 2013-2018E Dermatology Drug Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2013-2018E Dermatology Drug Sales Price Analysis
  5.6.4 India 2017 Dermatology Drug Market Share Analysis

6 GLOBAL 2013-2018E DERMATOLOGY DRUG SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2013-2018E Dermatology Drug Sales by Type
6.2 Different Types of Dermatology Drug Product Interview Price Analysis
6.3 Different Types of Dermatology Drug Product Driving Factors Analysis
  6.3.1 External Use Growth Driving Factor Analysis
  6.3.2 Oral Growth Driving Factor Analysis
  6.3.3 Injection Growth Driving Factor Analysis

7 GLOBAL 2013-2018E DERMATOLOGY DRUG SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2013-2018E Dermatology Drug Consumption by Application
7.2 Different Application of Dermatology Drug Product Interview Price Analysis
7.3 Different Application of Dermatology Drug Product Driving Factors Analysis
  7.3.1 Psoriasis of Dermatology Drug Growth Driving Factor Analysis
  7.3.2 Skin Infections of Dermatology Drug Growth Driving Factor Analysis
  7.3.3 Acne of Dermatology Drug Growth Driving Factor Analysis
  7.3.4 Dermatitis of Dermatology Drug Growth Driving Factor Analysis
  7.3.5 Other of Dermatology Drug Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF DERMATOLOGY DRUG

8.1 AbbVie
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 AbbVie 2017 Dermatology Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 AbbVie 2017 Dermatology Drug Business Region Distribution Analysis
8.2 Johnson & Johnson
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Johnson & Johnson 2017 Dermatology Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Johnson & Johnson 2017 Dermatology Drug Business Region Distribution Analysis
8.3 Bayer
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Bayer 2017 Dermatology Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Bayer 2017 Dermatology Drug Business Region Distribution Analysis
8.4 Galderma
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Galderma 2017 Dermatology Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Galderma 2017 Dermatology Drug Business Region Distribution Analysis
8.5 Bristol-Myers Squibb
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Bristol-Myers Squibb 2017 Dermatology Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Bristol-Myers Squibb 2017 Dermatology Drug Business Region Distribution Analysis
8.6 Novartis
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Novartis 2017 Dermatology Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Novartis 2017 Dermatology Drug Business Region Distribution Analysis
8.7 Pfizer
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Pfizer 2017 Dermatology Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Pfizer 2017 Dermatology Drug Business Region Distribution Analysis
8.8 Merz Pharma
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Merz Pharma 2017 Dermatology Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Merz Pharma 2017 Dermatology Drug Business Region Distribution Analysis
8.9 Valeant
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 Valeant 2017 Dermatology Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Valeant 2017 Dermatology Drug Business Region Distribution Analysis
8.10 LEO Pharma
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 LEO Pharma 2017 Dermatology Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 LEO Pharma 2017 Dermatology Drug Business Region Distribution Analysis
8.11 GlaxoSmithKline

9 DEVELOPMENT TREND OF ANALYSIS OF DERMATOLOGY DRUG MARKET

9.1 Global Dermatology Drug Market Trend Analysis
  9.1.1 Global 2018-2025 Dermatology Drug Market Size (Volume and Value) Forecast
  9.1.2 Global 2018-2025 Dermatology Drug Sales Price Forecast
9.2 Dermatology Drug Regional Market Trend
  9.2.1 North America 2018-2025 Dermatology Drug Consumption Forecast
  9.2.2 Europe 2018-2025 Dermatology Drug Consumption Forecast
  9.2.3 China 2018-2025 Dermatology Drug Consumption Forecast
  9.2.4 Japan 2018-2025 Dermatology Drug Consumption Forecast
  9.2.5 Southeast Asia 2018-2025 Dermatology Drug Consumption Forecast
  9.2.6 India 2018-2025 Dermatology Drug Consumption Forecast
9.3 Dermatology Drug Market Trend (Product Type)
9.4 Dermatology Drug Market Trend (Application)

10 DERMATOLOGY DRUG MARKETING TYPE ANALYSIS

10.1 Dermatology Drug Regional Marketing Type Analysis
10.2 Dermatology Drug International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Dermatology Drug by Region
10.4 Dermatology Drug Supply Chain Analysis

11 CONSUMERS ANALYSIS OF DERMATOLOGY DRUG

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL DERMATOLOGY DRUG MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Dermatology Drug
Table Product Specifications of Dermatology Drug
Table Classification of Dermatology Drug
Figure Global Production Market Share of Dermatology Drug by Type in 2017
Figure External Use Picture
Table Major Manufacturers of External Use
Figure Oral Picture
Table Major Manufacturers of Oral
Figure Injection Picture
Table Major Manufacturers of Injection
Table Applications of Dermatology Drug
Figure Global Consumption Volume Market Share of Dermatology Drug by Application in 2017
Figure Psoriasis Examples
Table Major Consumers in Psoriasis
Figure Skin Infections Examples
Table Major Consumers in Skin Infections
Figure Acne Examples
Table Major Consumers in Acne
Figure Dermatitis Examples
Table Major Consumers in Dermatitis
Figure Other Examples
Table Major Consumers in Other
Figure Market Share of Dermatology Drug by Regions
Figure North America Dermatology Drug Market Size (Million USD) (2013-2025)
Figure Europe Dermatology Drug Market Size (Million USD) (2013-2025)
Figure China Dermatology Drug Market Size (Million USD) (2013-2025)
Figure Japan Dermatology Drug Market Size (Million USD) (2013-2025)
Figure Southeast Asia Dermatology Drug Market Size (Million USD) (2013-2025)
Figure India Dermatology Drug Market Size (Million USD) (2013-2025)
Table Dermatology Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Dermatology Drug in 2017
Figure Manufacturing Process Analysis of Dermatology Drug
Figure Industry Chain Structure of Dermatology Drug
Table Capacity and Commercial Production Date of Global Dermatology Drug Major Manufacturers in 2017
Table Manufacturing Plants Distribution of Global Dermatology Drug Major Manufacturers in 2017
Table R&D Status and Technology Source of Global Dermatology Drug Major Manufacturers in 2017
Table Raw Materials Sources Analysis of Global Dermatology Drug Major Manufacturers in 2017
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Dermatology Drug 2013-2018E
Figure Global 2013-2018E Dermatology Drug Market Size (Volume) and Growth Rate
Figure Global 2013-2018E Dermatology Drug Market Size (Value) and Growth Rate
Table 2013-2018E Global Dermatology Drug Capacity and Growth Rate
Table 2017 Global Dermatology Drug Capacity (K Units) List (Company Segment)
Table 2013-2018E Global Dermatology Drug Sales (K Units) and Growth Rate
Table 2017 Global Dermatology Drug Sales (K Units) List (Company Segment)
Table 2013-2018E Global Dermatology Drug Sales Price (USD/Unit)
Table 2017 Global Dermatology Drug Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Dermatology Drug 2013-2018E
Figure North America 2013-2018E Dermatology Drug Sales Price (USD/Unit)
Figure North America 2017 Dermatology Drug Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Dermatology Drug 2013-2018E
Figure Europe 2013-2018E Dermatology Drug Sales Price (USD/Unit)
Figure Europe 2017 Dermatology Drug Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Dermatology Drug 2013-2018E
Figure China 2013-2018E Dermatology Drug Sales Price (USD/Unit)
Figure China 2017 Dermatology Drug Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Dermatology Drug 2013-2018E
Figure Japan 2013-2018E Dermatology Drug Sales Price (USD/Unit)
Figure Japan 2017 Dermatology Drug Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Dermatology Drug 2013-2018E
Figure Southeast Asia 2013-2018E Dermatology Drug Sales Price (USD/Unit)
Figure Southeast Asia 2017 Dermatology Drug Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Dermatology Drug 2013-2018E
Figure India 2013-2018E Dermatology Drug Sales Price (USD/Unit)
Figure India 2017 Dermatology Drug Sales Market Share
Table Global 2013-2018E Dermatology Drug Sales (K Units) by Type
Table Different Types Dermatology Drug Product Interview Price
Table Global 2013-2018E Dermatology Drug Sales (K Units) by Application
Table Different Application Dermatology Drug Product Interview Price
Table AbbVie Information List
Table Product Overview
Table 2017 AbbVie Dermatology Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 AbbVie Dermatology Drug Business Region Distribution
Table Johnson & Johnson Information List
Table Product Overview
Table 2017 Johnson & Johnson Dermatology Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Johnson & Johnson Dermatology Drug Business Region Distribution
Table Bayer Information List
Table Product Overview
Table 2017 Bayer Dermatology Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Bayer Dermatology Drug Business Region Distribution
Table Galderma Information List
Table Product Overview
Table 2017 Galderma Dermatology Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Galderma Dermatology Drug Business Region Distribution
Table Bristol-Myers Squibb Information List
Table Product Overview
Table 2017 Bristol-Myers Squibb Dermatology Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Bristol-Myers Squibb Dermatology Drug Business Region Distribution
Table Novartis Information List
Table Product Overview
Table 2017 Novartis Dermatology Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Novartis Dermatology Drug Business Region Distribution
Table Pfizer Information List
Table Product Overview
Table 2017 Pfizer Dermatology Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Pfizer Dermatology Drug Business Region Distribution
Table Merz Pharma Information List
Table Product Overview
Table 2017 Merz Pharma Dermatology Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Merz Pharma Dermatology Drug Business Region Distribution
Table Valeant Information List
Table Product Overview
Table 2017 Valeant Dermatology Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Valeant Dermatology Drug Business Region Distribution
Table LEO Pharma Information List
Table Product Overview
Table 2017 LEO Pharma Dermatology Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 LEO Pharma Dermatology Drug Business Region Distribution
Table GlaxoSmithKline Information List
Figure Global 2018-2025 Dermatology Drug Market Size (K Units) and Growth Rate Forecast
Figure Global 2018-2025 Dermatology Drug Market Size (Million USD) and Growth Rate Forecast
Figure Global 2018-2025 Dermatology Drug Sales Price (USD/Unit) Forecast
Figure North America 2018-2025 Dermatology Drug Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2018-2025 Dermatology Drug Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2018-2025 Dermatology Drug Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2018-2025 Dermatology Drug Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2018-2025 Dermatology Drug Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2018-2025 Dermatology Drug Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Dermatology Drug by Type 2018-2025
Table Global Consumption Volume (K Units) of Dermatology Drug by Application 2018-2025
Table Traders or Distributors with Contact Information of Dermatology Drug by Region


More Publications